Back to search

United Kingdom· GB-APID-41143111000001107

Ezetimibe 10mg tablets

A ezetimibe product containing ezetimibe, registered in United Kingdom by Milpharm Ltd. The same ATC class is registered in 17 of our 19 countries.

ATC C10AX09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedEzetimibe 10mg tabletsATCC10AX09REGISTER NO.GB-APID-4114311100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Ezetimibe is registered in 17 of 19 countries.

Countries holding a registration under ATC C10AX09 (ezetimibe), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Ezetimibe · ATC C10AX09

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ezetimibe costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.067 in United States to $1.32 in Switzerland — a ×20 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Ezetimibe · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.32
  • IT Italy$0.80
  • FR France$0.45
  • US United States$0.067 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ezetimibe
Manufacturer
Milpharm Ltd
Country
United Kingdom (GB)
ATC code
C10AX09
ATC class
Ezetimibe
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    08901175034468
  • gtin
    8901175034468

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for ezetimibe.

Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ezetimibe · interactions on record

236 records

  • 23 moderate
  • 2 minor
  • 210 info

Most severe, free to view

  • Chenodeoxycholic acidA05AA01moderate
  • EluxadolineA07DA06moderate
  • EltrombopagB02BX05moderate
  • SimvastatinC10AA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ezetimibe in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ezegelan, Ezetimib +pharma
  • Belgium · Ezetimib Ab, Ezetimibe Eg
  • Bulgaria · Езен, Езетимиб Адамед
  • Cyprus · Erezel, Ezetimibe Accord
  • Czechia · Egitim, Ezen
  • Germany · Ezetad, Ezetimib 1 A Pharma
  • Denmark · Carditimib, Cildar
  • Estonia · Ezetimibe Accord, Ezetimibe Elvim
  • Spain · Absorcol, Azibe
  • Finland · Ezetimib Krka, Ezetimib Liconsa
  • France · Ezetimibe Accord, Ezetimibe Almus
  • Greece · Cildar, Delipid
  • Croatia · Elanix, Ezetrol
  • Hungary · Coltowan, Ezetimib Egis
  • Ireland · Ezetimibe Accord Healthcare Ireland, Ezetimibe Krka
  • Iceland · Ezetimib Actavis, Ezetimib Krka
  • Italy · Absorcol, Corintus
  • Lithuania · Coltowan, Ezetimibe Elvim
  • Luxembourg · Ezetimib Ratiopharm, Ezetimibe Eg
  • Latvia · Ezetimibe Accord, Ezetimibe Elvim
  • Malta · Ezetimibe Msn, Ezoleta
  • Netherlands · Ezdivule, Ezetimibe Accord
  • Norway · Ezetimib Actavis, Ezetimib Krka
  • Poland · Coltowan, Etibax
  • Portugal · Ezetimiba Alter, Ezetimiba Aristo
  • Romania · Cexado, Coltowan
  • Sweden · Ezetimib Actavis, Ezetimib Krka
  • Slovenia · Elanix, Ezetrol
  • Slovakia · Ezen, Ezetimib Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd22fb02-1cad-43da-9207-b06fbf1532b6
GET /v1/drugs/bd22fb02-1cad-43da-9207-b06fbf1532b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "41143111000001107",
  "desc": "Ezetimibe 10mg tablets (Milpharm Ltd)",
  "form": "Oral tablet",
  "vpid": "42209811000001105",
  "source": "dmd",
  "vtm_id": "775914003",
  "strength": "10 mg",
  "substance": "Ezetimibe",
  "ingredient": "Ezetimibe",
  "supplier_code": "3313311000001100"
}

See everything about ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.